Metronidazole Benzoate CAS 13182-89-3 CAS NO.13182-89-3

Product description:
 

Metronidazole benzoate is parasitic disease drug resistance. Used in a variety of anaerobic bacteria infection, such as sepsis, endocarditis, pyothorax, lung abscess, abdominal cavity infection, pelvic infection, infection of department of gynaecology, bone and joint infection, meningitis, and brain abscesses, skin soft tissue infection, caused by clostridium difficile belongs antib-iotics related enteritis, helicobacter pylori gastritis or peptic ulcer disease, periodontal infection and Gardner vaginitis, etc

Benzoylmetronildazole is a new class of antiglycation agents used to treat diabetes mellitus. Benzoylmetronildazole is also a derivative of Metronidazole, an antibacterial in the treatment of rosacea.

This product has strong trichomonal killing effect and is the first choice for the treatment of vaginal trichomoniasis. It can be used to treat amoebic dysentery and amoebic liver abscess, and the curative effect is similar to that of emodin. This product has anti-anaerobic effect and can be used to treat postpartum pelvic inflammation, septicemia, periodontitis caused by anaerobic bacteria, etc.

 Fuction
1.Metronidazole is a nitroimidazoleantibiotic medication used particularly for anaerobicbacteria and protozoa. 
2.Metronidazole is an antibiotic, amebicide, and antiprotozoal. 
3.Metronidazole is the drug of choice for first episodes of mild-to-moderate Clostridium difficile infection.
4.Metronidazole has obvious effect for amebiasis